Abstract
We present a Peruvian human immunodeficiency virus (HIV)-positive patient receiving first-line therapy for tuberculosis who presents with neurological complications to highlight some of the major issues in the diagnosis and management of human immunodeficiency virus-related central nervous system complications in resource-poor settings. These include limited options for diagnosing extrapulmonary and drug-resistant tuberculosis; the importance of central nervous system . imaging; and the management conundrum when faced with a broad differential diagnosis. This patient was with drug-resistant tuberculosis of the brain, unmasked by immunologic recovery in the setting of recent initiation of antiretroviral treatment. We argue that aggressive and timely empiric multidrug-resistant tuberculosis treatment is important in cases where drug-resistant tuberculosis is suspected. Knowledge gaps include a limited understanding of immune reconstitution and the optimal timing of antiretroviral treatment in the setting of drug-resistant tuberculosis.
MeSH terms
-
AIDS-Related Opportunistic Infections* / diagnosis
-
AIDS-Related Opportunistic Infections* / drug therapy
-
AIDS-Related Opportunistic Infections* / microbiology
-
Adult
-
Anti-HIV Agents / therapeutic use
-
Antitubercular Agents / therapeutic use
-
Brain Diseases* / complications
-
Brain Diseases* / diagnosis
-
Brain Diseases* / drug therapy
-
Brain Diseases* / microbiology
-
HIV Infections* / complications
-
HIV Infections* / diagnosis
-
HIV Infections* / drug therapy
-
HIV Infections* / virology
-
Humans
-
Immune Reconstitution Inflammatory Syndrome
-
Magnetic Resonance Imaging
-
Male
-
Mycobacterium tuberculosis / isolation & purification
-
Peru
-
Poverty
-
Tomography, X-Ray Computed
-
Tuberculosis, Central Nervous System* / complications
-
Tuberculosis, Central Nervous System* / diagnosis
-
Tuberculosis, Central Nervous System* / drug therapy
-
Tuberculosis, Central Nervous System* / microbiology
-
Tuberculosis, Cutaneous* / complications
-
Tuberculosis, Cutaneous* / diagnosis
-
Tuberculosis, Cutaneous* / microbiology
-
Tuberculosis, Multidrug-Resistant / complications*
-
Tuberculosis, Multidrug-Resistant / diagnosis
-
Tuberculosis, Multidrug-Resistant / drug therapy
-
Tuberculosis, Multidrug-Resistant / microbiology
-
Urban Health
Substances
-
Anti-HIV Agents
-
Antitubercular Agents